用于菌体治疗的菌体的传播,净化和表征
Katarzyna Kosznik-Kwaśnicka1, Gracja Topka2, Jagoda Mantej2
1Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Methods in molecular biology (Clifton, N.J.)
|November 15, 2023
概括
菌体为对抗细菌感染提供了一个有希望的替代方案. 本研究详细介绍了菌体传播,净化和表征的方法,这对于开发菌体治疗应用至关重要.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 细菌感染对全球健康构成重大挑战,抗菌素耐药性日益增加,需要新的治疗策略.
- 菌体治疗,利用菌体 (菌体) 向特定的细菌,为传统抗生素提供了一个可行的替代方案.
- 菌体治疗的临床和兽医应用需要对菌体特性进行全面的理解和表征.
研究的目的:
- 介绍细菌菌体的传播,净化和微生物特征的方法.
- 描述从各种环境来源中分离出新型细菌菌体的过程.
- 评估分离的菌体对细菌生物膜的初步疗效,以及在Galleria mellonella感染模型中.
主要方法:
- 菌体传播技术,以产生足够数量的活菌体.
- 净化协议,以从细菌碎片和培养基中分离菌体.
- 微生物学表征包括宿主范围的确定,斑块测定和稳定性测试.
- 从各种环境样本 (如土壤,水) 中分离菌体.
- 在Galleria mellonella模型中对抗生物膜活性和体内疗效的体外评估.
主要成果:
- 建立了有效的菌体传播和净化协议.
- 描述了几种具有针对目标细菌菌株的特定性活性的菌体.
- 通过使用选定的菌体,在减少细菌生物膜方面取得了初步成功.
- 在Galleria mellonella模型中展示了菌体在治疗细菌感染方面的潜力.
结论:
- 提出的方法为构建治疗开发所必需的具有良好的特征的菌体库提供了基础.
- 菌体治疗作为对抗细菌感染的替代抗微生物策略具有显著的前景.
- 需要进一步的研究和验证才能将这些发现转化为临床和兽医实践.
相关概念视频
01:30Lytic Cycle of Bacteriophages
70.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
01:26DNA Bacteriophages
27
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
27
00:43Lysogenic Cycle of Bacteriophages
62.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.3K
01:20Viral Replication: Lytic Cycle
31
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
31
01:16Viral Replication: Lysogenic Cycle
31
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
31
01:29Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35